Takeda Pharmaceutical annual operating expenses
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Operating Expenses Growth & History (TAK)
Takeda Pharmaceutical's operating expenses was ¥2.47T for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | ¥2.47T | −¥189.07B | −7.11% |
| 2025 | 2025-03-31 | ¥2.66T | ¥35.74B | +1.36% |
| 2024 | 2024-03-31 | ¥2.62T | ¥330.11B | +14.40% |
| 2023 | 2023-03-31 | ¥2.29T | ¥291.58B | +14.57% |
| 2022 | 2022-03-31 | ¥2.00T | ¥307.08B | +18.13% |
| 2021 | 2021-03-31 | ¥1.69T | −¥406.78B | −19.36% |
| 2020 | 2020-03-31 | ¥2.10T | ¥893.21B | +73.95% |
| 2019 | 2019-03-31 | ¥1.21T | ¥174.99B | +16.94% |
| 2018 | 2018-03-31 | ¥1.03T | ¥15.39B | +1.51% |
| 2017 | 2017-03-31 | ¥1.02T | — | — |
Takeda Pharmaceutical quarterly operating expenses
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | ¥611.81B | ¥74.36B | +13.84% |
| Q4 2026 | 2026-03-31 | ¥646.77B | — | — |
| Q3 2026 | 2025-12-31 | ¥621.73B | — | — |
| Q2 2026 | 2025-09-30 | ¥663.74B | — | — |
| Q1 2026 | 2025-06-30 | ¥537.45B | — | — |
Takeda Pharmaceutical operating expenses trends
Over the last five fiscal years, Takeda Pharmaceutical's operating expenses increased from ¥1.69T to ¥2.47T, a change of ¥775.45B. The latest reported quarter, Q1 2027, shows ¥611.81B.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗